Back to Xpand.global
XPAND GLOBAL // EXECUTIVE TOOL

Know the risk
before the launch.

Pressure-test key elements of your international direct selling model and identify where market-specific friction may require restructuring.

Regulatory Risk Diagnostic Country Market Intelligence AI Compensation Plan Review
Executive Diagnostic Tool

Global Regulatory Exposure Diagnostic

Test your compensation targets and cross-border fulfillment against non-negotiable statutory caps before initiating foreign expansion.

48%
20% (Low) 35% (Korea Cap) 65% (Fatal)

Binary, Unilevel, or Matrix plans paying bonuses across 2+ levels.

Fulfilling orders via courier/postal mail without local sanitary notifications.

Jurisdictional Basis: Evaluated against Korea Door-to-Door Sales Act Art. 20, SAMR Order 444, and WFDSA top 21 market frameworks.
89%

Critical regulatory vulnerability detected across target markets.

Unlock Your Exposure Scorecard

Enter your corporate details to view your calculated legal risk tier and triggered statutory violation warnings.

Strictly confidential. Enterprise diagnostic data is never shared.

Important: This diagnostic is an executive screening tool and is not legal advice. Statutes, enforcement practices, licensing requirements and product rules can change and should be confirmed with qualified local counsel before launch.